HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Negotiations

PBM contracts, formulary dynamics, and the terms that matter

NegotiationsDrug Channels ↗
PBM Shakeout: How Vertical Integration Is Reshaping What’s Next (VIDEO)
Here at Drug Channels, we’ve been closely tracking the evolution of the pharmacy benefit management (PBM) indu…
May 20, 2026
Amgen expands crackdown on what it says is misuse of 340B program
NegotiationsEndpoints News ↗
Amgen expands crackdown on what it says is misuse of 340B program
Amgen is expanding its claims data requirements for pharmacies dispensing its drugs under the 340B federal dru…
May 15, 2026
Optum Rx unveils pharmacy model with clear fees, building on transparency push
NegotiationsEndpoints News ↗
Optum Rx unveils pharmacy model with clear fees, building on transparency push
UnitedHealth Group’s Optum Rx on Monday unveiled a new approach to prescription drug benefits that it said off…
May 11, 2026
NegotiationsDrug Channels ↗
Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels
Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Direct at GoodRx. L…
Apr 24, 2026
PANTHERx CEO: Rare Disease Pharmacy Requires Its Own Model
NegotiationsBriefing
PANTHERx CEO: Rare Disease Pharmacy Requires Its Own Model
Bansi Nagji says rare disease pharmacies must rethink every assumption of traditional specialty models, from s…
Apr 17, 2026
FTC’s Express Scripts Settlement Forces the Era of Net Pricing PBMs
Negotiations
FTC’s Express Scripts Settlement Forces the Era of Net Pricing PBMs
The 2026 FTC settlement compels Express Scripts to base patient costs on net, not list, prices—ending the reba…
Apr 17, 2026
Page 1 Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.